Dr. Maloney on Targets for CAR T-Cell Therapy – OncLive
OncLive |
Dr. Maloney on Targets for CAR T-Cell Therapy
OncLive David Maloney, MD, PhD, professor of medicine, Division of Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the success and challenges of chimeric antigen recptor (CAR) T-cell therapy in … |
